Shouru Zhang

570 total citations
18 papers, 439 citations indexed

About

Shouru Zhang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Shouru Zhang has authored 18 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Shouru Zhang's work include Redox biology and oxidative stress (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metastasis and carcinoma case studies (3 papers). Shouru Zhang is often cited by papers focused on Redox biology and oxidative stress (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Metastasis and carcinoma case studies (3 papers). Shouru Zhang collaborates with scholars based in China. Shouru Zhang's co-authors include Jinbao Guo, Jinlai Wei, Zhongxue Fu, Xingye Wu, Wei Zhang, Jihong Feng, Kunli Du, Zhongxue Fu, Jun Xu and Wei‐Dong Lü and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and Oncotarget.

In The Last Decade

Shouru Zhang

18 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shouru Zhang China 12 331 139 131 64 41 18 439
Kefeng Lei China 9 251 0.8× 141 1.0× 75 0.6× 46 0.7× 39 1.0× 20 364
Zhicheng Gong China 12 350 1.1× 136 1.0× 96 0.7× 66 1.0× 34 0.8× 26 490
Xiaoding Hu United States 13 284 0.9× 109 0.8× 132 1.0× 91 1.4× 40 1.0× 23 402
Chaoquan Hu China 10 284 0.9× 183 1.3× 111 0.8× 38 0.6× 31 0.8× 11 409
Yitao Wang China 10 230 0.7× 95 0.7× 89 0.7× 46 0.7× 31 0.8× 11 330
Guobin Fu China 10 313 0.9× 226 1.6× 91 0.7× 54 0.8× 23 0.6× 31 448
Sarah Courtois France 11 235 0.7× 133 1.0× 121 0.9× 47 0.7× 20 0.5× 16 358
Mincong Wang China 13 323 1.0× 200 1.4× 99 0.8× 67 1.0× 30 0.7× 25 478

Countries citing papers authored by Shouru Zhang

Since Specialization
Citations

This map shows the geographic impact of Shouru Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shouru Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shouru Zhang more than expected).

Fields of papers citing papers by Shouru Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shouru Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shouru Zhang. The network helps show where Shouru Zhang may publish in the future.

Co-authorship network of co-authors of Shouru Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shouru Zhang. A scholar is included among the top collaborators of Shouru Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shouru Zhang. Shouru Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Wang, Huang & Shouru Zhang. (2024). A watch-and-wait approach for metachronous multiple colon cancer following neoadjuvant immunotherapy: a case report. Frontiers in Immunology. 15. 1391038–1391038. 1 indexed citations
3.
Chen, Lihui, et al.. (2023). Clinical significance of the advanced lung cancer inflammation index in gastrointestinal cancer patients: a systematic review and meta-analysis. Frontiers in Oncology. 13. 1021672–1021672. 9 indexed citations
4.
Chen, Zhixiong, et al.. (2022). Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer. World Journal of Clinical Cases. 10(5). 1498–1507. 6 indexed citations
5.
Zhang, Shouru, et al.. (2022). Laparoscopic radical resection for situs inversus totalis with colonic splenic flexure carcinoma: A case report. World Journal of Clinical Cases. 10(16). 5435–5440. 2 indexed citations
6.
7.
Zhang, Shouru, et al.. (2019). Prdx2 Upregulation Promotes the Growth and Survival of Gastric Cancer Cells. Pathology & Oncology Research. 26(3). 1869–1877. 15 indexed citations
8.
Xu, Jun, Shouru Zhang, Rong Wang, et al.. (2017). Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway. Bioscience Reports. 37(3). 37 indexed citations
9.
Wei, Jinlai, Min Fang, Shouru Zhang, et al.. (2017). Sestrin 2 suppresses cells proliferation through AMPK/mTORC1 pathway activation in colorectal cancer. Oncotarget. 8(30). 49318–49328. 40 indexed citations
10.
Xiong, Yongfu, Rong Wang, Linglong Peng, et al.. (2017). An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer. Oncotarget. 8(49). 85463–85478. 28 indexed citations
11.
Wang, Rong, Jinlai Wei, Shouru Zhang, et al.. (2016). Peroxiredoxin 2 is essential for maintaining cancer stem cell-like phenotype through activation of Hedgehog signaling pathway in colon cancer. Oncotarget. 7(52). 86816–86828. 31 indexed citations
12.
13.
Li, Hui, Ziwei Wang, Wei Zhang, et al.. (2015). Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer. Cancer Letters. 370(1). 39–55. 56 indexed citations
14.
Li, Hui, Ziwei Wang, Wei Zhang, et al.. (2015). VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer. Medical Oncology. 32(3). 83–83. 41 indexed citations
15.
Zhang, Shouru, et al.. (2014). Peroxiredoxin 2 is involved in vasculogenic mimicry formation by targeting VEGFR2 activation in colorectal cancer. Medical Oncology. 32(1). 414–414. 32 indexed citations
16.
Du, Kunli, et al.. (2014). Hypoxia-inducible factor 1-alpha up-regulates the expression of phospholipase D2 in colon cancer cells under hypoxic conditions. Medical Oncology. 32(1). 394–394. 18 indexed citations
17.
Feng, Jihong, Zhongxue Fu, Jinbao Guo, et al.. (2014). Overexpression of peroxiredoxin 2 inhibits TGF-β1-induced epithelial-mesenchymal transition and cell migration in colorectal cancer. Molecular Medicine Reports. 10(2). 867–873. 26 indexed citations
18.
Guo, Jinbao, Zhongxue Fu, Jinlai Wei, et al.. (2014). PRRX1 promotes epithelial–mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer. Medical Oncology. 32(1). 393–393. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kefeng Lei Breakdown of academic impact, for papers by Zhicheng Gong Breakdown of academic impact, for papers by Xiaoding Hu Breakdown of academic impact, for papers by Chaoquan Hu Breakdown of academic impact, for papers by Yitao Wang Breakdown of academic impact, for papers by Guobin Fu Breakdown of academic impact, for papers by Sarah Courtois Breakdown of academic impact, for papers by Mincong Wang
Rankless by CCL
2026